Financials
- Market Capitalization 1.94 B
- Employee 291
- Founded 2004
- CEO N/A
- Website www.urogen.com
- Headquarter Israel
- FIGI N/A
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-6.52
売上高対価格比率
7.02
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2001 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 17.78 USD | -2.31% | -0.56% | +16.97% | +118.43% | 1.98 B USD | ||
| 2002 | IOVA Iovance Biotherapeutics, Inc. - Common Stock | 4.76 USD | +21.12% | +11.21% | +17.82% | +146.63% | 2.13 B USD | ||
| 2007 | SION Sionna Therapeutics, Inc. - Common Stock | 44.36 USD | +4.16% | +0.82% | +23.19% | +12.76% | 2.00 B USD | ||
| 2013 | NBTX Nanobiotix S.A. - ADSs | 39.76 USD | -4.51% | +2.47% | +12.32% | +654.46% | 1.92 B USD |